NO20056060L - Polyetylenoksidbaserte filmer og legemiddelleveringssystemer fremstilt fra disse - Google Patents

Polyetylenoksidbaserte filmer og legemiddelleveringssystemer fremstilt fra disse

Info

Publication number
NO20056060L
NO20056060L NO20056060A NO20056060A NO20056060L NO 20056060 L NO20056060 L NO 20056060L NO 20056060 A NO20056060 A NO 20056060A NO 20056060 A NO20056060 A NO 20056060A NO 20056060 L NO20056060 L NO 20056060L
Authority
NO
Norway
Prior art keywords
polyethylene oxide
films
drug delivery
delivery systems
oxide based
Prior art date
Application number
NO20056060A
Other languages
English (en)
Inventor
Robert K Yang
Richard C Fuisz
Gary L Myers
Joseph M Fuisz
Original Assignee
Monosolrx Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monosolrx Llc filed Critical Monosolrx Llc
Publication of NO20056060L publication Critical patent/NO20056060L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/18—Manufacture of films or sheets
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2371/00—Characterised by the use of polyethers obtained by reactions forming an ether link in the main chain; Derivatives of such polymers
    • C08J2371/02—Polyalkylene oxides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Manufacturing & Machinery (AREA)
  • Zoology (AREA)
  • Materials Engineering (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Oppfinnelsen vedrører de filmprodukter og fremgangsmåter for disses preparering som demonstrerer en ikke-selvaggregerende ensartet heterogenitet. Helst desintegreres filmene i vann og de kan dannes ved en kontrollert tørkeprosess, eller annen prosess som opprettholder filmens påkrevde ensartethet. Filmene inneholder en polymerkomponent, som inkluderer polyetylenoksid valgfritt blandet med hydrofile celluloseholdige polymerer. Helst inneholder filmene også et farmasøytisk og/eller kosmetisk aktivt agens med ikke mer enn et 10% avvik av det aktive farmasøytiske agens og/eller kosmetiske aktive agens pr. enhet areal av filmen.
NO20056060A 2003-05-28 2005-12-20 Polyetylenoksidbaserte filmer og legemiddelleveringssystemer fremstilt fra disse NO20056060L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47390203P 2003-05-28 2003-05-28
PCT/US2004/017076 WO2006031209A1 (en) 2003-05-28 2004-05-28 Polyethylene oxide-based films and drug delivery systems made therefrom

Publications (1)

Publication Number Publication Date
NO20056060L true NO20056060L (no) 2006-02-07

Family

ID=35811416

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20056060A NO20056060L (no) 2003-05-28 2005-12-20 Polyetylenoksidbaserte filmer og legemiddelleveringssystemer fremstilt fra disse

Country Status (8)

Country Link
EP (3) EP3210601A1 (no)
JP (1) JP4795962B2 (no)
CN (2) CN1812773B (no)
AU (2) AU2004319243B2 (no)
BR (1) BRPI0410956A (no)
CA (1) CA2544776C (no)
NO (1) NO20056060L (no)
WO (1) WO2006031209A1 (no)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040253310A1 (en) 2001-09-21 2004-12-16 Gina Fischer Morphine polymer release system
EP1429739A1 (en) 2001-09-21 2004-06-23 Egalet A/S Polymer release system
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US20080050422A1 (en) * 2001-10-12 2008-02-28 Monosolrx, Llc. Method of administering a film product containing a drug
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
EP1610767B1 (en) 2003-03-26 2011-01-19 Egalet A/S Morphine controlled release system
DK1799453T3 (da) * 2004-09-30 2012-12-17 Monosolrx Llc Flerlagsfilm med ensartet indhold
WO2008028047A2 (en) * 2006-08-30 2008-03-06 Lab International Srl Bioadhesive film drug delivery system
WO2008036299A2 (en) * 2006-09-20 2008-03-27 Monosol Rx Llc Edible water-soluble film containing a foam reducing flavoring agent
PL2248519T3 (pl) 2006-10-02 2018-04-30 Apr Applied Pharma Research S.A. Niemukoadhezyjne postaci dawkowania w postaci filmu
AU2008206362A1 (en) * 2007-01-12 2008-07-24 Monosol Rx Llc High dose film compositions and methods of preparation
US20080292683A1 (en) * 2007-05-24 2008-11-27 Monosolrx, Llc. Film shreds and delivery system incorporating same
US8821928B2 (en) 2007-06-04 2014-09-02 Egalet Ltd. Controlled release pharmaceutical compositions for prolonged effect
US8298583B2 (en) 2007-10-19 2012-10-30 Monosol Rx, Llc Film delivery system for tetrahydrolipstatin
JP2011526888A (ja) * 2008-07-01 2011-10-20 ザ・ジョンズ・ホプキンス・ユニバーシティ 治療薬を標的送達するための経口速溶性薄膜
WO2010086989A1 (ja) 2009-01-29 2010-08-05 日東電工株式会社 口腔内フィルム状基剤及び製剤
WO2010089132A1 (en) 2009-02-06 2010-08-12 Egalet A/S Immediate release composition resistant to abuse by intake of alcohol
DK2442650T3 (en) 2009-06-12 2015-12-07 Cynapsus Therapeutics Inc sublingual apomorphine
EP2445487A2 (en) 2009-06-24 2012-05-02 Egalet Ltd. Controlled release formulations
TR201902233T4 (tr) 2009-10-30 2019-03-21 Ix Biopharma Ltd Hızlı çözünen katı dozaj formu.
JP5588688B2 (ja) 2010-01-28 2014-09-10 日東電工株式会社 フィルム状製剤
US8577488B2 (en) * 2010-02-11 2013-11-05 Monosol Rx, Llc Method and system for optimizing film production and minimizing film scrap
US20110236666A1 (en) * 2010-03-26 2011-09-29 Hall Mark J Melt-extruded film
JP5751868B2 (ja) 2010-03-30 2015-07-22 日東電工株式会社 フィルム状製剤及びその製造方法
JP5800527B2 (ja) * 2010-03-30 2015-10-28 日東電工株式会社 安定化医薬組成物、安定化医薬組成物溶液製剤、フィルム状製剤及びフィルム状製剤の製造方法
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
US20120107402A1 (en) * 2010-10-29 2012-05-03 Monosol Rx, Llc Process for analyzing and establishing dosage size in an ingestible film
NZ612686A (en) 2010-12-16 2015-11-27 Cynapsus Therapeutics Inc Sublingual films
JP5841433B2 (ja) 2012-01-11 2016-01-13 日東電工株式会社 口腔内フィルム状基剤及び製剤
JP2015521988A (ja) 2012-07-06 2015-08-03 イガレット・リミテッド 制御放出用乱用防止性医薬組成物
WO2014176449A1 (en) * 2013-04-25 2014-10-30 Rinsenergy LLC Oral rinse composition and method to deliver energy supplements
WO2015001541A2 (en) 2014-09-25 2015-01-08 Shilpa Medicare Limited Pharmaceutical film composition
US20160220480A1 (en) * 2015-02-03 2016-08-04 Intelgenx Corp. Oral dosage film exhibiting enhanced mucosal penetration
EP3072502B1 (en) * 2015-03-25 2020-07-08 Universitätsmedizin der Johannes Gutenberg-Universität Mainz Rheological blood replacement solution and uses thereof
JP7211706B2 (ja) 2015-04-21 2023-01-24 サノヴィオン ファーマシュティカルズ インコーポレーテッド 口腔粘膜へのアポモルフィンの投与によるパーキンソン病の治療方法
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
JP2019519487A (ja) 2016-05-05 2019-07-11 アクエスティブ セラピューティクス インコーポレイテッド 送達増強エピネフリン組成物
CN109688834A (zh) * 2016-05-13 2019-04-26 圭尔夫大学 用于挥发性化合物的控制释放的组合物
EP4371554A3 (en) 2016-12-31 2024-08-07 BioXcel Therapeutics, Inc. Use of sublingual dexmedetomidine for the treatment of agitation
EP3565642A1 (en) * 2017-01-09 2019-11-13 The Procter and Gamble Company Barrier patch with soluble film and methods of improving skin appearance
DE102017103346A1 (de) * 2017-02-17 2018-08-23 Lts Lohmann Therapie-Systeme Ag Strukturierte orodispergierbare Filme
WO2018166432A1 (en) * 2017-03-13 2018-09-20 Nano And Advanced Materials Institute Limited High loading and fast disintegration film for fast drug absorption
DE102017112527B4 (de) * 2017-06-07 2019-01-03 Lts Lohmann Therapie-Systeme Ag Schnell zerfallende Schaumwafer mit hohem Flächengewicht
CN107325332B (zh) * 2017-07-07 2018-10-26 许辉良 速溶羟丙基甲基纤维素及其制备方法
SG11202012772XA (en) 2018-06-27 2021-01-28 Bioxcel Therapeutics Inc Film formulations containing dexmedetomidine and methods of producing them
CN109382996B (zh) * 2018-12-05 2024-04-30 无锡会通轻质材料股份有限公司 一种中空epp珠粒挤出机构
US11723838B2 (en) * 2019-05-02 2023-08-15 TearClear Corp. Preservative removal from eye drops
WO2021016112A2 (en) 2019-07-19 2021-01-28 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
CN111238199B (zh) * 2020-01-16 2024-08-02 肇庆方兴包装材料有限公司 一种解决薄膜之间粘连的生产工艺
EP3895692A1 (en) * 2020-04-15 2021-10-20 LTS Lohmann Therapie-Systeme AG Oral thin film with smooth fused film
CN111592670A (zh) * 2020-06-24 2020-08-28 上海应用技术大学 γ-聚谷氨酸分子印迹聚合物膜的制备方法
WO2022055985A1 (en) * 2020-09-08 2022-03-17 Nutrativa Llc Dissolvable matrices
CN112472593B (zh) * 2020-11-24 2022-06-10 牡丹江医学院 一种加入甜味剂掩盖苦味的口腔溃疡药膜加工设备
CN114230840A (zh) * 2022-01-28 2022-03-25 孙琇芳 一种水溶可控型聚乙烯醇薄膜
CN114410044A (zh) * 2022-01-28 2022-04-29 孙琇芳 一种水溶型真空包装保鲜膜及其使用方法
CN114848612A (zh) * 2022-04-28 2022-08-05 青岛博益特生物材料股份有限公司 一种片状材料覆膜工艺及其生产的覆膜片状材料
CN115414876A (zh) * 2022-09-07 2022-12-02 天津科技大学 一种纤维素纳米纤丝凝胶的平板微波浓缩装置、方法和应用
CN116294531A (zh) * 2023-01-05 2023-06-23 安徽腾远化工科技有限公司 一种氨基模塑料高效烘干设备
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
CN116589019B (zh) * 2023-05-26 2023-10-27 深圳市一号芯环保科技有限公司 一种长效缓释型杀菌及抗氧化功能滤芯材料及制备方法
CN118384560B (zh) * 2024-06-26 2024-08-23 广东蜀丰科技有限公司 一种泡沫分散均匀的消泡分散机

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136145A (en) 1974-07-05 1979-01-23 Schering Aktiengesellschaft Medicament carriers in the form of film having active substance incorporated therein
US4631837A (en) 1985-05-31 1986-12-30 Magoon Richard E Method and apparatus for drying fruit pulp and the like
EP0219762B1 (de) 1985-10-09 1990-12-27 Desitin Arzneimittel GmbH Verfahren zur Herstellung einer Darreichungs- und Dosierungsform für Arzneimittel-Wirkstoffe, Reagentien oder andere Wirkstoffe
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
DE3630603A1 (de) * 1986-09-09 1988-03-10 Desitin Arzneimittel Gmbh Darreichungs- und dosierungsform fuer arzneimittelwirkstoffe, reagentien oder dergleichen sowie verfahren zu deren herstellung
DE4018247A1 (de) 1990-06-07 1991-12-12 Lohmann Therapie Syst Lts Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen
IT1249315B (it) * 1991-05-23 1995-02-22 Euroresearch Srl Lamina di collageno non poroso per uso terapeutico, metodo ed apparecchiature per ottenerlo
US5393528A (en) * 1992-05-07 1995-02-28 Staab; Robert J. Dissolvable device for contraception or delivery of medication
AU679937B2 (en) * 1992-11-18 1997-07-17 Johnson & Johnson Consumer Products, Inc. Extrudable compositions for topical or transdermal drug delivery
US20010006677A1 (en) * 1996-10-29 2001-07-05 Mcginity James W. Effervescence polymeric film drug delivery system
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
US6153210A (en) * 1997-08-14 2000-11-28 Periodontix, Inc. Use of locally delivered metal ions for treatment of periodontal disease
US6072100A (en) * 1998-01-28 2000-06-06 Johnson & Johnson Consumer Products, Inc. Extrudable compositions for topical or transdermal drug delivery
US6281337B1 (en) 1998-11-12 2001-08-28 Schering Corporation Methods for conversion of protein isoforms
DE19960154A1 (de) * 1999-12-14 2001-07-12 Lohmann Therapie Syst Lts Flache Arzneizubereitung zur transmucosalen Verabreichung von Oxycodon oder einem vergleichbaren Wirkstoff in der Mundhöhle, für die Anwendung in der Schmerztherapie und Suchttherapie
EP1110546A1 (en) * 1999-12-23 2001-06-27 Johnson & Johnson Consumer Companies, Inc. Method of preparing a water soluble film
US7067116B1 (en) * 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
US6375981B1 (en) * 2000-06-01 2002-04-23 A. E. Staley Manufacturing Co. Modified starch as a replacement for gelatin in soft gel films and capsules
WO2003003957A1 (en) * 2001-07-06 2003-01-16 Lavipharm Laboratories Inc. Quick dissolving oral mucosal drug delivery device with moisture barrier coating
CA2473967C (en) * 2001-10-12 2011-06-14 Monosolrx Llc Thin film with non-self-aggregating uniform heterogeneity, process for their production and drug delivery systems made therefrom
EP1458367B2 (en) * 2001-10-12 2021-01-27 Aquestive Therapeutics, Inc. Uniform films for rapidly dissolving dosage form incorporating taste-masking compositions
EP2428206A1 (en) * 2003-01-30 2012-03-14 MonoSol RX LLC Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom

Also Published As

Publication number Publication date
BRPI0410956A (pt) 2006-07-04
CN1812773A (zh) 2006-08-02
EP2716284A2 (en) 2014-04-09
CA2544776A1 (en) 2006-03-23
CN1812773B (zh) 2012-06-27
JP4795962B2 (ja) 2011-10-19
EP1663178A1 (en) 2006-06-07
EP3210601A1 (en) 2017-08-30
CA2544776C (en) 2014-04-15
AU2004319243A8 (en) 2008-08-07
AU2004319243A1 (en) 2006-01-12
AU2004319243B2 (en) 2010-06-03
JP2007500252A (ja) 2007-01-11
EP2716284A3 (en) 2014-11-05
WO2006031209A1 (en) 2006-03-23
CN102670568A (zh) 2012-09-19
AU2010214780A1 (en) 2010-09-23

Similar Documents

Publication Publication Date Title
NO20056060L (no) Polyetylenoksidbaserte filmer og legemiddelleveringssystemer fremstilt fra disse
WO2008100375A3 (en) Polymer-based films and drug delivery systems made therefrom
Wu et al. Swelling-strengthening hydrogels by embedding with deformable nanobarriers
ES2486848T3 (es) Producto de confitería
Li et al. Polymer nanocoating of amorphous drugs for improving stability, dissolution, powder flow, and tabletability: The case of chitosan-coated indomethacin
Hsu et al. Multimonth controlled small molecule release from biodegradable thin films
Maver et al. Polysaccharide thin solid films for analgesic drug delivery and growth of human skin cells
US8691278B2 (en) Self solidifying bioerodible barrier implant
AU1387002A (en) New cross-linked derivatives of hyaluronic acid
Ahmad et al. Enhancement of oral insulin bioavailability: in vitro and in vivo assessment of nanoporous stimuli-responsive hydrogel microparticles
WO2006073430A3 (en) Therapeutic delivery system comprising a high molecular weight peg-like compound
Maksym‐Bębenek et al. Study on Self‐Assembled Well‐Defined PEG Graft Copolymers as Efficient Drug‐Loaded Nanoparticles for Anti‐Inflammatory Therapy
Pertici et al. Inputs of macromolecular engineering in the design of injectable hydrogels based on synthetic thermoresponsive polymers
NO20056241L (no) Nanopartikler av polyoksyetylenerte derivater
Shin et al. Effect of polyethylene glycol molecular weight on cell growth behavior of polyvinyl alcohol/carboxymethyl cellulose/polyethylene glycol hydrogel
Martin et al. Oxidation‐responsive, tunable growth factor delivery from polyelectrolyte‐coated implants
Ning et al. On-demand prolongation of peripheral nerve blockade through bupivacaine-loaded hydrogels with suitable residence periods
Dadou et al. Elucidation of the controlled-release behavior of metoprolol succinate from directly compressed xanthan gum/chitosan polymers: Computational and experimental studies
Gajra et al. Mucoadhesive hydrogel films of econazole nitrate: formulation and optimization using factorial design
Gunbas et al. Semi-IPN chitosan/PEG microspheres and films for biomedical applications: characterization and sustained release optimization
Riccio et al. Chitosan/nanocellulose‐based bionanocomposite films for controlled betamethasone and silver sulfadiazine delivery
Kwon et al. Preparation of erythromycin-loaded poly (vinylalcohol) film and investigation of its feasibility as a transdermal delivery carrier
Ju et al. Punicalagin-loaded alginate/chitosan-gallol hydrogels for efficient wound repair and hemostasis
Khan et al. Effects of cyclodextrins (β and γ) and l-arginine on stability and functional properties of mucoadhesive buccal films loaded with omeprazole for pediatric patients
Laezza et al. Polysaccharide-Enriched Electrospun Nanofibers for Salicylic Acid Controlled Release

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: AQUESTIVE THERAPEUTICS INC., US

FC2A Withdrawal, rejection or dismissal of laid open patent application